Fenfei Zou
Sendagi, 1138603, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
Journal: International journal of clinical oncology
Published: January 03, 2023
Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression.
Journal: Anticancer research
Published: November 20, 2017
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer.
Journal: Oncotarget
Published: August 16, 2017
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Journal: Oncology reports
Published: October 17, 2016
Prognostic significance of ABCB1 in stage I lung adenocarcinoma.
Journal: Oncology letters
Published: September 09, 2015
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Journal: Molecular cancer therapeutics
Published: January 18, 2015
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Journal: BMC cancer
Published: May 13, 2014
Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed.
Journal: International journal of oncology
Published: January 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026